- Report
- June 2025
- 209 Pages
Global
From €2190EUR$2,500USD£1,900GBP
- Report
- February 2026
- 194 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- February 2026
- 576 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- February 2026
- 182 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- September 2025
- 250 Pages
Global
From €3932EUR$4,490USD£3,413GBP
- Report
- January 2026
- 180 Pages
Global
From €3941EUR$4,500USD£3,421GBP
- Report
- January 2026
- 182 Pages
Global
From €3941EUR$4,500USD£3,421GBP
- Report
- August 2025
- 146 Pages
Global
From €3502EUR$3,999USD£3,040GBP
- Report
- October 2025
- 160 Pages
Global
From €3459EUR$3,950USD£3,003GBP
- Report
- July 2025
- 150 Pages
Global
From €4248EUR$4,850USD£3,687GBP
- Report
- August 2025
- 123 Pages
North America
From €3502EUR$3,999USD£3,040GBP
- Report
- July 2025
- 250 Pages
Asia Pacific
From €3389EUR$3,869USD£2,941GBP
- Report
- November 2023
- 124 Pages
Global
From €3941EUR$4,500USD£3,421GBP
- Report
- January 2023
- 124 Pages
Global
From €1971EUR$2,250USD£1,710GBP
- Report
- December 2024
- 150 Pages
Global
From €5211EUR$5,950USD£4,523GBP
- Report
- October 2024
- 200 Pages
Global
From €4334EUR$4,949USD£3,762GBP
- Report
- January 2025
- 129 Pages
Global
From €3502EUR$3,999USD£3,040GBP
- Report
- October 2020
- 120 Pages
Global
From €2190EUR$2,500USD£1,900GBP
- Report
- February 2024
- 94 Pages
Global
From €3500EUR$4,281USD£3,144GBP
- Report
- October 2023
- 96 Pages
Global
From €3500EUR$4,281USD£3,144GBP

The Mono Vaccine market is a subset of the larger Vaccines market, which is composed of products designed to prevent or reduce the severity of infectious diseases. Mono Vaccines are a type of vaccine that protect against a single pathogen, such as measles, mumps, rubella, or varicella. These vaccines are typically administered to children and are often combined with other vaccines to form a combination vaccine. Mono Vaccines are typically administered in a single dose, and are often given in combination with other vaccines to form a combination vaccine.
The Mono Vaccine market is highly competitive, with a number of companies offering products. Some of the major players in the market include Merck & Co., GlaxoSmithKline, Sanofi Pasteur, Pfizer, and Novartis. Other companies in the market include AstraZeneca, CSL, Emergent BioSolutions, and Johnson & Johnson. Show Less Read more